Azenta(NASDAQ) AZTA

Market Cap$1.35B

Since IPO (1995)+292%

5 Year-66%

1 Year+5%

1 Month-4%

Premium Feature

Moneyball Superscore

45/100

$30.75

-1.85%

-0.58Today

After hours$30.82+$0.07 (+0.23%)

Azenta last closing stock price
Metric	Price	Date
Last close	USD 30.82	2026-09-08

Azenta stock price return by period
Period	Price return	Price at period start	Period start date
1 week	-2.38%	USD 31.57	2026-09-01
1 month	-3.81%	USD 32.04	2026-08-07
3 month	+37.71%	USD 22.38	2026-06-10
Year to date	-7.34%	USD 33.26	2025-12-31
1 year	+4.58%	USD 29.47	2025-09-08
3 year	-40.92%	USD 52.17	2023-09-08
5 year	-66.01%	USD 90.67	2021-09-09
Since inception	+292.19%	USD 7.86	1995-02-02

Azenta Financials at a Glance

Market Cap

$1.35B

Revenue (TTM)

$613.81M

Net Income (TTM)

-$122.90M

EPS (TTM)

-$2.67

P/E Ratio

-11.56

Dividend

$0.00

Beta (Volatility)

1.44 (Average)

Dividend

$0.00

Beta (Volatility)

1.44 (Average)

Price

$30.75

Volume

1,159,911.662

Open

$30.82

Price

$30.75

Volume

1,159,911.662

Open

$30.82

Previous Close

$30.82

Daily Range

$30.66 - $31.66

52-Week Range

$15.93 - $41.73

Estimated Earnings Date

Nov 20, 2026

Dividend

$0.00

Beta (Volatility)

1.44 (Average)

Price

$30.75

Volume

1,159,911.662

Open

$30.82

Previous Close

$30.82

Daily Range

$30.66 - $31.66

52-Week Range

$15.93 - $41.73

Estimated Earnings Date

Nov 20, 2026

AZTA News

3 Stocks Poised for Huge Growth Over the Next Decade

Ryan DownieJan 27, 2021

This Cold Stock Might Be Ready to Heat Up

PT LathropJun 5, 2020

Brooks Automation Ends Its Fiscal Year With Brisk Life Sciences Growth

Asit Sharma, CPANov 7, 2019

Why Yum China Holdings, Brooks Automation, and Geron Jumped Today

Dan CaplingerAug 28, 2018

Page 1

AZTA: Motley Fool Moneyball Superscore

Our CEO Is Handing Members His Secret Weapon

It's called Motley Fool Moneyball, our new proprietary AI tool

We spent over half a million dollars in R&D to build a tool that makes stock research faster, sharper, and smarter. Our analysts use it every day, and now, you can too.

Get Access Now

About Azenta

Azenta, Inc. helps scientists store and study biological samples. These tools help researchers manage millions of biological specimens. The company serves drug developers and universities finding new treatments.

Cold Storage and Genetic Tools

Sample Management Solutions: Automated ultra-cold storage systems and repository services for chemical compounds; segment revenue was $88.3 million for the quarter ended June 30, 2026.
Multiomics Services: Genomic services like gene sequencing and synthesis used to develop new medicines; segment revenue was $72.9 million for the quarter ended June 30, 2026.
Consumables and Instruments: Specialized tubes and devices for handling samples during research and development workflows.
Sample Integrity Tools: Systems that ensure biological samples stay secure and viable throughout their lifecycle.

Reshaping the Portfolio

Acquired UK Biocentre for $27.5 million on March 4, 2026, to expand European sample storage capacity.
Completed the $63.0 million sale of the B Medical Systems business on July 1, 2026, to simplify operations.
Established a new European operational hub in the United Kingdom to support biotechnology and public health customers.
Repurchased 2.3 million shares of common stock for $50.0 million through June 30, 2026, under a new buyback program.

Connecting Labs Around the World

The company operates a global sales network covering approximately 75 countries across North America, Asia, and Europe. It maintains a workforce of 2,900 employees and contingent workers to support its precision automation and genomic research services.

Key Performance Metrics

Revenue was $161.2 million for the quarter ended June 30, 2026, up 12% year over year.
Operating loss grew to $177.2 million for the nine-month period ended June 30, 2026.
Recorded a $149.1 million non-cash goodwill impairment charge during the second quarter of fiscal year 2026.
Held $528.5 million in cash, cash equivalents, and marketable securities as of June 30, 2026.

The Big Picture

Azenta has transformed from an industrial business into a specialized provider of life science sample solutions. This shift allows the company to focus on high-value areas like genomic sequencing and automated cold storage.

AI Generated • Aug 7, 2026

Industry

Life Sciences Tools and Services

Sector

Health Care

Employees

2,900

CEO

John P. Marotta, MBA

Website

www.azenta.com

Headquarters

Burlington, MA 01803, US

AZTA Financials

Key Financial Metrics (TTM)

Gross Margin

44.05%

Operating Margin

-3.49%

Net Income Margin

-20.02%

Return on Equity

-7.56%

Return on Capital

-0.61%

Return on Assets

-6.55%

Earnings Yield

-8.65%

Dividend Yield

0.00%

Payout Ratio

0.00%

Stock Overview

Market Cap

$1.35B

Shares Outstanding

43.81M

Volume

1.16M

Avg. Volume

726.37K

Financials (TTM)

Gross Profit

$270.37M

Operating Income

-$21.40M

EBITDA

-$96.62M

Operating Cash Flow

$37.98M

Capital Expenditure

-$28.09M

Free Cash Flow

$9.88M

Cash & ST Invst.

$325.80M

Total Debt

$53.97M

Azenta Performance Analysis

Azenta annual revenue and year-over-year revenue growth by fiscal year
Fiscal year	Period end	Revenue	YoY growth
2022	2022-09-30	USD 555,498,000	8.1%
2023	2023-09-30	USD 665,072,000	19.7%
2024	2024-09-30	USD 573,448,000	-13.8%
2025	2025-09-30	USD 593,821,000	3.6%

Azenta sequential (quarter-over-quarter) revenue growth by fiscal quarter
Fiscal quarter	Period end	QoQ growth
Q4	2025-09-30	10.6%
Q1	2025-12-31	-6.6%
Q2	2026-03-31	-2.6%
Q3	2026-06-30	11.3%

Azenta annual diluted earnings per share and year-over-year EPS growth by fiscal year
Fiscal year	Period end	Diluted EPS	YoY growth
2022	2022-09-30	USD -5.73	N/A
2023	2023-09-30	USD -0.22	-96.2%
2024	2024-09-30	USD -3.10	1341.0%
2025	2025-09-30	USD -1.22	-60.7%

Azenta sequential (quarter-over-quarter) diluted earnings per share growth by fiscal quarter
Fiscal quarter	Period end	QoQ growth
Q4	2025-09-30	188.7%
Q1	2025-12-31	-133.3%
Q2	2026-03-31	-926.5%
Q3	2026-06-30	101.4%

Revenue Growth Rate

Annual and quarterly growth comparison

Earnings Per Share Growth Rate

Annual and quarterly EPS growth comparison

Quarterly Performance

Name

Q3 2026YOY CHG

Revenue

$161.18M

+12.0%

Gross Profit

$72.36M

+6.8%

Gross Margin

44.89%

N/A

Market Cap

$1.35B

N/A

Market Cap/Employee

$465.58K

N/A

Employees

2,900

N/A

Net Income

$2.46M

+104.7%

EBITDA

$14.43M

-20.6%

Quarterly Fundamentals

Name

Q3 2026YOY CHG

Total Cash

$325.80M

+2.2%

Total Debt

$53.97M

+2.5%

Accounts Receivable

$143.68M

+15.4%

Inventory

$79.08M

-1.8%

Long Term Debt

$53.97M

+2.5%

Short Term Debt

$0.00

N/A

Return on Assets

-6.55%

N/A

Return on Invested Capital

-1.33%

N/A

Free Cash Flow

-$3.87M

-125.8%

Operating Cash Flow

$2.77M

-89.3%

Other Investments to Explore

People Also Watch

SymbolSymbol / CompanyCompanyPricePrice Chg

SDGRSchrödinger, Inc.

SDGRSchrödinger, Inc.$20.03-0.30%

STAASTAAR Surgical Company

STAASTAAR Surgical Company$24.16+2.94%

KMTSKestra Medical Technologies, Ltd.

KMTSKestra Medical Technologies, Ltd.$25.64+0.37%

TDOCTeladoc Health, Inc.

TDOCTeladoc Health, Inc.$6.26-0.32%

BLFSBioLife Solutions, Inc.

BLFSBioLife Solutions, Inc.$35.38+0.37%

NVCRNovocure Ltd

NVCRNovocure Ltd$16.85-6.08%

EVOEvotec SE

EVOEvotec SE$1.82-2.15%

Trending Stocks

SymbolSymbol / CompanyCompanyPricePrice Chg

INTCIntel

INTCIntel$104.47+0.09%

NVDANvidia

NVDANvidia$225.73-0.02%

ATAIAtaiBeckley

ATAIAtaiBeckley$7.28-0.01%

NOKNokia

NOKNokia$10.65+0.06%

SPCXSpace Exploration Technologies

SPCXSpace Exploration Technologies$153.47+0.04%

TSLLDirexion Shares ETF Trust - Direxion Daily Tsla Bull 2x ETF

TSLLDirexion Shares ETF Trust - Direxion Daily Tsla Bull 2x ETF$9.87+0.08%

NUNu Holdings

NUNu Holdings$15.33-0.00%

Questions About AZTA

What is the current price of Azenta?

Azenta is trading at $30.82 per share.

What is the 52-week range for Azenta?

Over the past 52 weeks, Azenta has traded between $15.93 and $41.73.

How much debt does Azenta have?

As of the most recent reporting period, Azenta reported total debt of $53.97M.

How much cash does Azenta have on hand?

Azenta reported $192.07M in cash and cash equivalents in its most recent financial results.

What is Azenta’s dividend yield?

Azenta does not currently have a dividend yield.

Azenta(NASDAQ) AZTA

Azenta Financials at a Glance

AZTA News

Why a $5 Million Bet on Azenta Could Pay Off After a 70% Stock Slide

Azenta (AZTA) Q3 EPS Jumps 36%

Why Azenta Stock Is Tumbling Today

Why Brooks Automation Shot Nearly 9% Higher Today

3 Stocks Poised for Huge Growth Over the Next Decade

This Cold Stock Might Be Ready to Heat Up

Brooks Automation Ends Its Fiscal Year With Brisk Life Sciences Growth

Why Yum China Holdings, Brooks Automation, and Geron Jumped Today

AZTA: Motley Fool Moneyball Superscore

Our CEO Is Handing Members His Secret Weapon

About Azenta

Cold Storage and Genetic Tools

Reshaping the Portfolio

Connecting Labs Around the World

Key Performance Metrics

The Big Picture

AZTA Financials

Key Financial Metrics (TTM)

Stock Overview

Financials (TTM)

Azenta Performance Analysis

Revenue Growth Rate

Earnings Per Share Growth Rate

Quarterly Performance

Quarterly Fundamentals

Other Investments to Explore

People Also Watch

Trending Stocks

Questions About AZTA

What is the current price of Azenta?

What is the 52-week range for Azenta?

How much debt does Azenta have?

How much cash does Azenta have on hand?

What is Azenta’s dividend yield?

Premium Investing Services